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Purpose: The pursuit of a dietary source to increase urine pH and citrate in stone formers 
has been ongoing for more than 30 years. Early evidence showed that orange juice (OJ) 
contains alkali and citrate but high sugar and ascorbic acid content limited the use of OJ as 
a viable daily source of alkali. Recently, novel low calorie OJs have emerged and could 
potentially be a better option.  
Methods: Beverages with high concentrations of alkali citrate and malate were identified 
using ion chromatography. Two low calorie OJ beverages, in addition to Crystal Light 
Lemonade (CLLB) were chosen. Healthy volunteers (5 men, 5 women) drank 1L of OJ or 
CLLB with 1L water daily for 7 days and then completed a 24-hour urinalysis. A washout 
week was instituted between trial weeks. The study design is a prospective randomized 
cross over control trial. A paired analysis using comparison of means was used to evaluate 
low calorie OJ and CLLB. Volunteers had no prior history of kidney stones and maintained a 
journal with beverage compliance, side effect, and dietary consumption data.  
Results: Tropicana 50 (TRP50), Kroger low calorie OJ (KLCO) and CLLB were found to have a 
total alkali content of 56.60, 47.9, and 17.3 mEq/L, respectively, based on ion 
chromatography. Consumption of all three beverages raised urinary citrate (116.6 [-118 to 
373, 177.9 [-3 to 359], 155.6 [-4 to 237] mg/d 95% CI) and urinary pH (0.25 [0.08-0.53], 
0.74 [0.41-1.07 p<0.05], 0.25 [0.25-0.64]) respectively, compared to water phase. Based on 
journal entries by volunteers, TRP50 had the most side effects (90% participants) felt to be 
a result of the artificial sweetener (Stevia ®).  
Conclusion: Low-calorie orange juice, and to a lesser extent CLLB, have alkali and citrate 


















































































































































































































































Dietary alternatives to modify urinary derangements such as hypocitraturia or aciduria 
have been explored for more than 30 years(1). Low urinary citrate and pH can promote 
calcium oxalate and uric acid stone formation, respectively. The current AUA guidelines 
state that potassium citrate (kcit) therapy should be initiated for patients with recurrent 
calcium stones and low urinary citrate, and uric acid or cystine stone formers with low 
urinary pH(2). Unfortunately, compliance rates with kcit are poor because of 
gastrointestinal side effects, poor palatability, large pill size(3) and cost(4). Rampant 
increases in the price of generic medications, such as kcit, occur when pharmaceutical 
companies obtain a market share of a drug’s production or supply(5). This has been 
identified as a relatively new issue affecting kcit compliance rates.  
There are multiple publications on dietary sources of alkali and citrate. Wabner et al. 
published one of the earliest series in 1993 looking at orange juice (OJ) as an alternative 
source for citrate to prevent kidney stones(6). Additionally, lemon-based beverages have 
been evaluated extensively both in both bench(7) and clinical settings(8-10). Changing urinary 
citrate and pH levels with concentrated lemon extract, lemonade, grapefruit(11), raspberry 
and coconut juice(12) have had mixed results. Despite early evidence that OJ harbored 
excellent alkali potential, valid concerns over the sugar content in OJ, in combination with 
the promising bench results of concentrated lemon juice led to a focused effort evaluating 
the efficacy of lemon-based beverages on urinary citrate and pH modulation. Eisner et al. 
published a summary of the alkali potential of multiple lemon-based beverages(13). 
Interestingly, despite its frequent utilization, the paper did not feature Crystal Light 
Lemonade beverage (CLLB) as there is little to no research on CLLB as an alternative source 
of alkali therapy. After multiple trials(8-10) evaluating the effectiveness of lemon-based 
beverages, the results are still inconclusive; supporting continued efforts to find 
alternative sources of dietary citrate and alkali therapy.  One example is the use of novel 
low calorie OJ drinks with the potential to provide dietary citrate or alkali without large 
















































































































































































































































Our group decided to evaluate the potential for urinary citrate and pH with low calorie OJ 
beverages. Prior to any clinical application of low calorie OJ in stone patients, we wanted 
to evaluate the alkali potential in popular consumer beverages; these included low calorie 
OJ and CLLB. We hypothesized that low calorie OJ and CLLB would have favorable alkali 
potential based on ion chromatography. After identifying beverages with favorable profiles 
based on ion chromatograph that were easily accessible and cost effective, we 
hypothesized that consumption of these specific beverages by healthy volunteers would 
yield urinary alkalization with concomitant increases in urinary citrate. 
Methods 
Using an ICS 2000 system equipped with an AS-11 analytical column with KOH elutent 
(Dionex, Sunnyvale, California), ion chromatography was completed on common consumer 
beverages to evaluate for total citrate, malate, and alkali potential. The pK of tricarboxylic 
acid citrate was used to calculate anion content was 3.1, 4.7, 6.4 and for dicarboxylic 
malate the pK was 3.4, and 5.1 respectively. Anion peaks were detected by a conductivity 
meter with eluent background conductivity suppressed by an ASRS® Ultra II anion self-
regenerating suppressor. The pH of each beverage was measured with a pH electrode. 
Various brands of standard and low-calorie OJ, Crystal Light Lemon and orange, and 
carbonated flavored water were selected for the initial analysis. Unprotonated citrate and 
malate anion concentrations were obtained and used to calculate the total alkali content 
of each beverage expressed in mEq/L.  
From the initial analysis, two low-calorie OJ options [Tropicana 50 (TRP50) and Kroger Low 
Calorie (KLCO) brand] along with CLLB were selected for clinical evaluation. All of the 
commercial orange beverages had robust concentrations of alkali, however, TRP50 was 
chosen because it is widely available for purchase at stores such as Target, Walmart, and 
on Amazon.com. KLCO was selected because it was locally available and the cheapest 
option of low calorie OJ options. CLLB was included as a zero-calorie option for those who 
might not tolerate the extra calories of even low calorie OJ. The study was structured as a 
randomized prospective cross-over study that evaluated the 24-hour urine parameters of 















































































































































































































































history of kidney stones. The volunteers were recruited via word of mouth and flyers 
posted around the hospital after the study received institutional review board-approval. 
Each volunteer was assigned a randomized drink order which included: 2L water/day, 1L 
low-calorie TRP50 OJ and 1L water/day, 1L KLCO and 1L water/day, or 1L CLLB and 1 L 
water/day. Each beverage was consumed for 7 continuous days. Validation that volunteers 
were not consuming vitamins or medications that would affect their 24-hour urinalysis 
occurred upon enrollment. No other dietary restrictions were enforced. After 7 days of 
each beverage consumption a 24-hour urine collection was completed and sent to 
Litholink Corporation for testing. Between each trial beverage there was a one-week 
washout period where volunteers had no dietary restrictions. The trial took 8 weeks to 
complete for each volunteer.  The Litholink urinary panel provides measures including, but 
not limited to, citrate, calcium, oxalate, phosphate, uric acid and urinary pH. Volunteers 
maintained a diary where they recorded adherence to the beverage consumption 
requirements, any side effects from the beverages, and a description of their meals while 
on a trial week. These journals were reviewed at the conclusion of the trial to ensure 
consistency in dietary habits between the trial weeks and compliance with beverage 
consumption at the prescribed volumes. Paired changes in mean citrate excretion, pH, and 
urine volume were the primary endpoints of the study and were conducted using an 
ANOVA comparison of means.  A p value of <0.05 is considered statistical significance.   
Results 
Results of the chemical analysis are represented in table 1.  We found that Minute Maid 
pure Squeeze 50 had the highest citrate composition (45 mmol/L) of all the beverages 
analyzed while LaCroix Orange (<0.2 mmol/L) and Crystal Light Orange (15.5 mmol/L) had 
the lowest. All the OJ drinks provided a large total alkali and potassium load. CLLB 
demonstrated an intermediate alkali load with 17.3 mEq/L. In table 2, 24-hour average 
urine results are listed by drink category. All collections were evaluated for their 
appropriateness (Cr24/kg) with average baseline values of 25.8 ± 3.8 and 22.1 ± 3.6 
respectively for male and female volunteers. The only statistical difference between the 
groups was change in urinary pH (CLLB, 0.25 [0.08-0.53]; KLCO, 0.74 [0.41-1.07 p<0.05]; 















































































































































































































































177.9 [-3 to 359]; TRP50, 155.6 [-4 to 237] mg/d [95% CI]) by not statistically significant 
in a paired difference test (table 3). Changes in urinary volume, citrate and urinary pH with 
TRP50 compared to KCLO were less; likely the result of a reduced beverage consumption 
at high volumes from gastrointestinal side effects potentially a result, in part, by the 
artificial sweetener. Volunteers reported side effects (S.E - 90%), including gastrointestinal 
side effects (bloating, diarrhea, acid reflux) and headaches with TRP50 which were less 
prevalent (30%) and severe with KLCO. Intestinally, other than 3 patients complaining of 
the taste, no one reported any side effects associated with CLLB consumption. All 
participants validated that they were compliant with the volume of water and trial 
beverage for the trial week, with the exception of one participant who could not complete 
a week of TRP50 because of headaches and abdominal cramping. CLLB did raise urinary pH 
by 0.25 (p=0.99), urinary volume almost 200mL (p=0.008), and citrate levels 155mg/day 
(p=0.05) compared to values obtained during the water phase.   
Discussion 
Dietary sources of alkali and citrate have been identified. Common consumer beverages 
have been primarily evaluated because they have more consistent concentrations of 
bioavailable alkali salts and they provide the potential to increase dietary fluid intake.  The 
AUA guidelines clearly outline that patients being treated for hypocitraturia or aciduria can 
reduce their risk of recurrent calcium oxalate or uric acid stone disease with supplemental 
citrate and alkali therapy(2). Potassium citrate has long been the mainstay therapy to 
restore urinary citrate and pH levels(14). However, there are a number of challenges 
associated with potassium citrate therapy that negatively impact patient compliance. The 
typical dose of potassium citrate ranges from 20 – 60 mEq/day which a recent publication 
estimated to cost up to $5100 annually(15). For most patients, this is unaffordable, 
especially when insurance denies coverage. The prevalence of stones in the United States 
is increasing(16) and preventative therapies are paramount to minimize patient morbidity 
and mitigate health costs. Finding a dietary alternative, especially in a beverage, is 
imperative to reduce or replace our dependence on costly prescription-based medications 















































































































































































































































The early evidence that OJ has good alkali potential compared to alternate beverages(6) has 
largely been overlooked because of valid concerns about the associated sugar and caloric 
content. To some extent, this aided in the proliferation of lemon-based beverage studies. 
Lemon-based beverages can be consumed in large volumes and they avoid the 
introduction of stone substrates such as ascorbic acid. However, lemonade and lemon-
based beverages have had mixed results(8,10,15) with urinary citrate modulation or urine 
alkalization in healthy volunteers or recurrent stone formers (table 4). A recent publication 
by Eisner et al, explains that dietary citrate exists as a salt coupled with potassium, 
calcium, sodium, magnesium or as an acid(13). In the case of lemon-based beverages the 
predominant cation is hydrogen, which neutralizes any systemic alkali potential from the 
conversion of citrate to bicarbonate by the liver. Additionally, pure lemon juice has to be 
diluted to improve its palatability; factors which could be the reason for the variability in 
urinary citrate and pH modulation with lemon-based beverages. Despite a lower alkali 
content associated with CLLB compared to all OJ beverages on ion chromotography (table 
1), we did see increases in both citrate, urine volume, and urinary pH in healthy volunteers 
from baseline levels on 24-hour urinalyses with CLLB. Even though the statistical 
significance may be lacking, our results do align with previous publications (table 4) that in 
a paired-difference analysis, CLLB, on average, raised urinary volume, citrate and pH 
compared to baseline.  
By comparison, in addition to raising urinary citrate and volume, KCLO did show a 
statistically significant increase in average paired difference of urinary pH. Wabner et al. 
demonstrated the same finding in 1993(6) with standard OJ which was further supported 
by Odvina et al. in 2006(17) (table 4). These studies are limited in that they used high 
volumes of pure OJ in a controlled environment and dietary regimen which confers large 
dietary sugar loads and somewhat unrealistic lifestyle expectations of patients. The 
volunteers in this study demonstrated that consumption of KLCO can raise the urinary pH, 
with less sugar, within the stresses of daily life and activity. Based on the average paired 
difference of 0.74 pH units between baseline and KCLO urine samples, KCLO could be 
implemented into the prevention of uric acid or calcium oxalate stones in patients with 















































































































































































































































showed increases in urinary oxalate likely resulting from higher dietary consumption of 
ascorbic acid (table 4). however, these have limited clinical impact and can potentially be 
mitigated with increased dietary calcium consumption and avoidance of specific foods rich 
in oxalate. Additionally, based on diary logs, 30% of volunteers had GI S.E. (two described 
bloating and one suffered abdominal cramps) from consuming KLCO. Although there were 
no compliance issues with the daily consumption of 1L of KLCO, we did see issues with 
TRP50. Multiple volunteers (90%) reported S.E. with TRP50 which we hypothesized was 
caused by the artificial sweetener (Stevia®) resulting in one patient withdrawing from the 
TRP50 trial week. We feel there is a clinical application of low-calorie OJ in the prevention 
of nephrolithiasis, however, a specific type and possibly lower daily volume may be 
required before formal recommendations can be established.  
The concerns over our dependence on potassium citrate as the primary source for alkali 
and citrate is prompting multiple parallel studies of dietary alternatives(18-19). Aside from 
lemon and orange-based beverages, other drinks, including grapefruit juice and coconut 
water have shown similar changes in urinary citrate and pH after controlled consumption 
in healthy volunteers(11-12). Compared to controls, after 4-7 days of grapefruit juice or 
coconut water consumption, urinary pH and citrate did increase, but these changes were 
all non-significant except for the increase in urinary citrate concentration after coconut 
water consumption (table 4). By comparison, all beverage trials that used OJ (including this 
study for pH), showed statistical increases in urinary pH and citrate after 7 days of 
consumption (table 3,4). Concerns over the sugar, ascorbic acid, and artificial sweetener 
load with the consumption of low calorie OJ on overall gut microbiome health, stone 
metabolite absorption and any underlying metabolic syndrome will persist with the use of 
OJ, however, a better alternative to increase urinary pH is still lacking. For example, 
Lytholyte ® asserts 45mEq of alkali therapy for $2.25 per day(18) with no guaranteed fluid 
volume consumption compared to KCLO which confers an average increase of 400mL of 
urine at $1.46 per day for the same amount of alkali. To providers, we would recommend 
trying different brands of low calorie OJ if patients report poor palatability. The findings 















































































































































































































































OJ is safe to consume in patients with a history of nephrolithiasis, hypocitraturia, aciduria 
and potentially metabolic syndrome.  
This study is not without limitations. Despite being a prospective randomized, cross-over 
trial, the sample size of volunteer participants is small. Nevertheless, we were able to 
demonstrate a statistical difference in urinary pH when volunteers consumed KLCO. We 
realize that in the study design we did not control diet, environment, and activity, 
however, we did review the volunteer journals and could not identify any noteworthy 
variances in beverage compliance or diet variability amongst the volunteers. We feel this 
study design is still representative of how urinary modulation can be achieved despite the 
inherent variability when research is conducted in a real-world setting. Additionally, the 
external validity of our results may have a limited potential when applied to patients with 
hypocitraturic or aciduric nephrolithiasis. These patients typically have comorbidities, for 
instance: metabolic syndrome, that may limit their ability to safely consume daily low-
calorie OJ because of the additional sugar intake. Additionally, it is unclear in a diseased 
state such a hypocitratic nephrolitahsis with comorbidities like metabolic syndrome how 
low-calorie OJ consumption will translate into systemic or urinary alkalinization. Further 
research is underway to evaluate the potential positive urinary changes daily low-calorie 
OJ consumption can have in patients with hypocitraturic or aciduric nephrolithiasis.   
Conclusion 
There are a variety of options to introduce natural sources of alkali and citrate salts into 
the diet. In healthy volunteers, our study supports the use of both low-calorie OJ and CLLB 
to modulate urinary characteristics; namely urinary pH. Additional work is underway to 
evaluate if the same outcomes can be achieved in patients with nephrolithiasis, 
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AUA = American Urologic Association 
BMI = Body Mass Index 
CLLB = Crystal Light Lemonade Beverage 
kcit = Potassium Citrate 
KLCO = Kroger Low Calorie Orange Juice 
L = Liter 
Miliequivalents = mEq 
OJ = Orange Juice 
TRP50 = Tropicana 50 Orange Juice 
S.E. = Side Effect 

















































































































































































































































Table 1: Results from ion chromatography on common consumable beverages completed 
with the assistance of Litholink Lab Corp.  























Crystal Light Orange 3.2
46 
15.5 < 0.2 9.1 <2 0 10 
Crystal Light Lemonade 3.2
18 
30.4 < 0.2 17.3 6.4 0 10 
Minute Maid Pure Squeezed 50 
Calories, No Pulp 
3.9
64 
45.2 8.6 52.8 53.4 42 208 
Trop50, No Pulp 3.8
94 
37.4 24.7 56.1 51.6 42 208 
Trop50, Some Pulp (SUP) 3.8
24 
37.1 23.5 57.6 48.5 42 208 
LaCroix Orange 5.2
00 
< 0.2 < 0.2 
  
0 0 
Tropicana, No Pulp 3.9
03 




Kroger Low-calorie OJ 3.9
78 




Simply Orange, Pulp (SUP)  3.9
24 
















































































































































































































































Table 2: Averages of 24-hr urinalysis for common urinary parameters for each beverage. 
Statistical significance set at p<0.05, pH (bolded) was the only variable that showed 
statistical significance between the groups on ANOVA.  
Table 2 Control CLLB KLCO TRP50 
Number of participants 10 10 10 9 
Volume (L/day) 2.5 ± 1.2 2.7 ± 1.1 2.9 ± 1.3 2.2 ± 1.0 




36.8 ± 7.7 46.4 ± 8.2 
42.2 ± 
18.3 






6.93 ± 0.41 
6.63 ± 
0.42 





0.65 ± 0.28 
0.68 ± 
0.34 















32.2 ± 17.5 
33.2 ± 
13.3 














42.4 ± 25.1 
49.4 ± 
33.1 
Creatinin24/kg (mg/kg/day) -        
Male 
25.1 ± 4.2 26.4 ± 2.3 25.5 ± 3.2 26.1 ± 6.6 
















































































































































































































































Table 3: Average of the paired difference between trial beverage and control. Statistical 
significance set at p<0.05, change pH (bolded) was the only variable that showed statistical 
significance between the groups on ANOVA. △ represents change in.  
* When KCLO is compared to TRP50 for △Vol (mL) p= 0.012 and for △Cit24 (mg/day) p= 
























(n=10) 196 11.6 -1.71 155.65 +0.25 2.87 -1.22 
KLCO 
(n=10) 387* -29.43 7.90 177.98* +0.74 7.10 24.28 
TRP50 




















































































































































































































































Table 4: Summary of published literature evaluating the urinary changes seen with the 
consumption of beverages hypothesized to have high concentrations of bioavailable alkali 
and citrate. # Comparison was conducted between a baseline metabolic evaluation and 
therapeutic intervention- significant differences in paired differences are reported as 
bolded value. Bolded values indicate significant differences between control and trial 
beverage, p<0.05  
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